Atara Biotherapeutics, Inc. short interest in 2018
In 2018, Atara Biotherapeutics, Inc.'s disclosed short interest ran from 16.97% of shares outstanding on 12 Jan 2018 to 14.37% on 31 Dec 2018, a change of -2.60 percentage points. The year's high was 21.80% on 13 Apr 2018 and its low 13.16% on 15 Oct 2018, averaging 15.33% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.01 days on 31 Jul 2018. Full history: Atara Biotherapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 16.97% (12 Jan 2018)
- End of year
- 14.37% (31 Dec 2018)
- Change
- -2.60 pp
- High
- 21.80% (13 Apr 2018)
- Low
- 13.16% (15 Oct 2018)
- Average
- 15.33%
- Highest days to cover
- 18.01 (31 Jul 2018)
- SEC filings marked
- 8
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 16.97% | 3.64 | |
| 31 Jan 2018 | 15.74% | 3.52 | |
| 15 Feb 2018 | 16.40% | 4.81 | |
| 28 Feb 2018 | 16.30% | 7.37 | 10-K filed, results (8-K) |
| 15 Mar 2018 | 14.15% | 4.57 | |
| 29 Mar 2018 | 17.73% | 5.85 | |
| 13 Apr 2018 | 21.80% | 10.92 | |
| 30 Apr 2018 | 15.40% | 14.39 | |
| 15 May 2018 | 15.00% | 14.62 | 10-Q filed, results (8-K) |
| 31 May 2018 | 15.97% | 12.20 | |
| 15 Jun 2018 | 15.25% | 10.57 | |
| 29 Jun 2018 | 16.22% | 8.19 | |
| 13 Jul 2018 | 15.25% | 16.28 | |
| 31 Jul 2018 | 14.98% | 18.01 | |
| 15 Aug 2018 | 14.10% | 12.61 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 13.64% | 12.01 | |
| 14 Sep 2018 | 13.71% | 11.00 | |
| 28 Sep 2018 | 14.15% | 6.86 | |
| 15 Oct 2018 | 13.16% | 11.84 | |
| 31 Oct 2018 | 14.38% | 15.28 | |
| 15 Nov 2018 | 14.10% | 10.60 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 14.34% | 11.10 | |
| 14 Dec 2018 | 14.83% | 12.86 | |
| 31 Dec 2018 | 14.37% | 13.09 |
See also: Atara Biotherapeutics, Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.